4UB0 | pdb_00004ub0

New design for monovalent bispecific IgG through cysteine engineering of the CH1-CL interface


Domain Annotation: SCOP/SCOPe Classification SCOP-e Database Homepage

Domain Annotation: ECOD Classification ECOD Database Homepage

ChainsFamily NameDomain Identifier ArchitecturePossible HomologyHomologyTopologyFamilyProvenance Source (Version)
B [auth L]PTR2e4ub0L1 A: a/b three-layered sandwichesX: cradle loop barrelH: RIFT-relatedT: acid proteaseF: PTR2ECOD (v294.1)
A [auth H]PTR2e4ub0H2 A: a/b three-layered sandwichesX: cradle loop barrelH: RIFT-relatedT: acid proteaseF: PTR2ECOD (v294.1)
A [auth H]EF-hand_1, EF-hand_6, EF-hand_7e4ub0H3 A: a/b three-layered sandwichesX: Lipocalins/StreptavidinH: SAM/DNA-glycosylaseT: SAM domain-likeF: EF-hand_1, EF-hand_6, EF-hand_7ECOD (v294.1)

Domain Annotation: CATH CATH Database Homepage

ChainDomainClassArchitectureTopologyHomologyProvenance Source (Version)
B [auth L]2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (4.3.0)
A [auth H]2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (4.3.0)

IMGT Antibody Annotation IMGT Database Homepage

ChainProtein NameDescriptionOrganism NameGene Allele Name(s)Domain Name(s)Receptor TypeReceptor DescriptionProvenance Source
B [auth L]IgG1 Fab L-KAPPA Homo sapiens (human) IGKV1-39*01, IGKV1D-39*01, IGKJ1*01, IGKC*01 V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA IG FAB-GAMMA-1_KAPPA IMGT (202611-0)
A [auth H]IgG1 Fab VH-CH1 Homo sapiens (human) IGHV3-66*01, IGHV3-66*02, IGHV3-66*04, IGHJ6*01, IGHJ6*02, IGHG1*01, IGHG1*02, IGHG1*04, IGHG1*05 V-DOMAIN VH, C-DOMAIN CH1 IG FAB-GAMMA-1_KAPPA IMGT (202611-0)

SAbDab Antibody Annotation SAbDab Database Homepage

ChainChain ClassChain SubclassChain TypeAntigen Name(s) Provenance Source
B [auth L]Light ChainIGKV1 Kappa-SAbDab (2026-03-27)
A [auth H]Heavy ChainIGHV3 --SAbDab (2026-03-27)

Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage

ChainNameTargetProvenance Source
B [auth L] Coprelotamab ERBB2/CD340/HER2, CD3E, SIRPA, TNFRSF9/CD137/4-1BBTherapeutic SAbDab (2026-03-27)
A [auth H] Coprelotamab ERBB2/CD340/HER2, SIRPA, CD3E, TNFRSF9/CD137/4-1BBTherapeutic SAbDab (2026-03-27)